<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-pharmaceutics-13-00387">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Whittaker</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Currie</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Turner</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Field</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Mulla</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Pandya</surname>
    <given-names>H.C.</given-names>
   </name>
  </person-group>
  <article-title>Toxic additives in medication for pre-term infants</article-title>
  <source>Arch. Dis. Child. Fetal Neonatal Ed.</source>
  <year>2009</year>
  <volume>94</volume>
  <fpage>236</fpage>
  <lpage>240</lpage>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://fn.bmj.com/content/94/4/F236" xmlns:xlink="http://www.w3.org/1999/xlink">https://fn.bmj.com/content/94/4/F236</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-05-20">(accessed on 20 May 2020)</date-in-citation>
  <pub-id pub-id-type="doi">10.1136/adc.2008.146035</pub-id>
 </element-citation>
</ref>
